ES526869A0 - Un procedimiento para la preparacion de un derivado de pirazol - Google Patents

Un procedimiento para la preparacion de un derivado de pirazol

Info

Publication number
ES526869A0
ES526869A0 ES526869A ES526869A ES526869A0 ES 526869 A0 ES526869 A0 ES 526869A0 ES 526869 A ES526869 A ES 526869A ES 526869 A ES526869 A ES 526869A ES 526869 A0 ES526869 A0 ES 526869A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
pyrazole derivative
pyrazole
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526869A
Other languages
English (en)
Other versions
ES8601900A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8601900A1 publication Critical patent/ES8601900A1/es
Publication of ES526869A0 publication Critical patent/ES526869A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES526869A 1982-11-01 1983-10-28 Un procedimiento para la preparacion de un derivado de pirazol Granted ES526869A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/437,994 US4495195A (en) 1982-11-01 1982-11-01 Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use

Publications (2)

Publication Number Publication Date
ES8601900A1 ES8601900A1 (es) 1985-05-01
ES526869A0 true ES526869A0 (es) 1985-05-01

Family

ID=23738785

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526869A Granted ES526869A0 (es) 1982-11-01 1983-10-28 Un procedimiento para la preparacion de un derivado de pirazol

Country Status (13)

Country Link
US (1) US4495195A (es)
EP (1) EP0112623A2 (es)
JP (1) JPS5995272A (es)
KR (1) KR840006629A (es)
AU (1) AU2068583A (es)
DD (1) DD210265A5 (es)
DK (1) DK492783D0 (es)
ES (1) ES526869A0 (es)
FI (1) FI833931A (es)
GB (1) GB2130205A (es)
GR (1) GR79640B (es)
IL (1) IL70075A0 (es)
PT (1) PT77583B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
JPS6425763A (en) 1987-04-24 1989-01-27 Mitsubishi Chem Ind Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
US4861777A (en) * 1987-09-11 1989-08-29 Mitsubishi Kasei Corporation Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient
JP2751309B2 (ja) * 1988-02-16 1998-05-18 三菱化学株式会社 ピラゾール類およびこれを有効成分とする殺虫、殺ダニ、殺菌剤
JP2784925B2 (ja) * 1988-09-07 1998-08-13 日本農薬株式会社 3又は5−フェニルピラゾール類又はその塩及び除草剤
CA2036192A1 (en) 1990-02-13 1991-08-14 Nicholas Meanwell Heterocyclic carboxylic acids and esters
US4956379A (en) * 1990-02-13 1990-09-11 Bristol-Myers Squibb Company Pyrazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US5436258A (en) * 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
HRP950330A2 (en) * 1994-07-05 1997-10-31 Ciba Geigy Ag New herbicides
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
US5723608A (en) * 1996-12-31 1998-03-03 Neurogen Corporation 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
WO1999024038A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
WO2006022375A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. 2-フェニルチオフェン誘導体
WO2006022374A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. 2-フェニルピリジン誘導体
DE602006018635D1 (de) 2005-10-07 2011-01-13 Astellas Pharma Inc Triarylcarbonsäurederivat
EP1992361B1 (en) 2006-02-24 2012-05-02 Astellas Pharma Inc. Remedy or preventive for digestive ulcer
CN102333765B (zh) 2009-02-27 2015-01-14 帝人制药株式会社 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法
SG187843A1 (en) 2010-08-27 2013-03-28 Teijin Pharma Ltd Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
EP2980085B1 (en) 2013-03-29 2018-03-14 Teijin Pharma Limited Pyrazole derivative
EP2944635B1 (en) * 2014-05-15 2018-11-28 Council of Scientific & Industrial Research Pyrazole linked benzimidazole conjugates and a process for preparation thereof
CN106632245B (zh) * 2016-09-30 2019-11-15 华南理工大学 氮取代基苯基吡唑类黄嘌呤氧化还原酶抑制剂及制备与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1261124B (de) * 1961-09-22 1968-02-15 Hoechst Ag Verfahren zur Herstellung von Pyrazolen
IT1053661B (it) * 1966-09-27 1981-10-10 Farmacosmici S P A Ammidi dell acido 3 5 metil 5 3 pirazol carbossilico
FR2104931B1 (es) * 1970-09-08 1975-01-10 Ferlux
DE2508934A1 (de) * 1974-03-04 1975-09-11 Byk Gulden Lomberg Chem Fab Neue substituierte 5-amino-4- formyl-carbamoyl-pyrazole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2410653A1 (de) * 1974-03-06 1975-10-30 Byk Gulden Lomberg Chem Fab Neue heterocyclisch substituierte 5amino-4-formylcarbamoyl-pyrazole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US3899508A (en) * 1974-04-12 1975-08-12 Lilly Co Eli 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof
US3895027A (en) * 1974-04-12 1975-07-15 Lilly Co Eli Process for preparing pyrazole-3-carboxylic acids
US3903106A (en) * 1974-04-12 1975-09-02 Lilly Co Eli Pyrazole-3-carboxylic acids
FR2353292A1 (fr) * 1975-08-05 1977-12-30 Sogeras Nouveaux derives du benzoyl-3 pyrazole
FR2320093A1 (fr) * 1975-08-05 1977-03-04 Sogeras Nouveaux acides diphenyl-pyrazole-5-acetiques
US4134987A (en) * 1976-01-14 1979-01-16 Huppatz John L Compounds and compositions
US4214090A (en) * 1976-01-14 1980-07-22 Commonwealth Scientific And Industrial Research Organization Fungicidal carboxamidopyrazoles
US4245106A (en) * 1979-07-05 1981-01-13 Monsanto Company Process for the preparation of 1-alkyl-3-aryl-4-pyrazolecarboxylates
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives

Also Published As

Publication number Publication date
DK492783D0 (da) 1983-10-27
EP0112623A2 (en) 1984-07-04
PT77583A (en) 1983-11-01
KR840006629A (ko) 1984-12-01
AU2068583A (en) 1984-05-10
JPS5995272A (ja) 1984-06-01
GB8328755D0 (en) 1983-11-30
ES8601900A1 (es) 1985-05-01
US4495195A (en) 1985-01-22
DD210265A5 (de) 1984-06-06
GB2130205A (en) 1984-05-31
PT77583B (en) 1986-05-27
IL70075A0 (en) 1984-01-31
GR79640B (es) 1984-10-31
FI833931A (fi) 1984-05-02
FI833931A0 (fi) 1983-10-27

Similar Documents

Publication Publication Date Title
ES526869A0 (es) Un procedimiento para la preparacion de un derivado de pirazol
ES530714A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES505517A0 (es) Un procedimiento para la preparacion de un derivado de n- arilbenzamida
ES504103A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES505950A0 (es) Un procedimiento para la preparacion de un derivado de tia- zol
ES548672A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES526295A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES505678A0 (es) Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol
ES502994A0 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
ES502792A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES531659A0 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES535980A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES546905A0 (es) Un procedimiento para la preparacion de derivados de pirazol
ES530669A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
ES536982A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES504764A0 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
ES504376A0 (es) Un procedimiento para la preparacion de un derivado de fene-tilamina
ES540345A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES500911A0 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES541840A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolilo
ES527232A0 (es) Un procedimiento para la preparacion de nuevos derivados de triazol
ES498145A0 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas